+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Integrative Medicine in Head and Neck Cancer



Integrative Medicine in Head and Neck Cancer



Otolaryngology--Head and Neck Surgery 156(2): 228-237



Objective Complementary and alternative medicine, or integrative medicine, has become increasingly popular among patients with head and neck cancer. Despite its increasing prevalence, many patients feel uncomfortable discussing such therapies with their physicians, and many physicians are unaware and underequipped to evaluate or discuss their use with patients. The aim of this article is to use recent data to outline the decision making inherent to integrative medicine utilization among patients with head and neck cancer, to discuss the ethical implications inherent to balancing integrative and conventional approaches to treatment, and to highlight available resources to enhance head and neck cancer providers' understanding of integrative medicine. Data Sources Randomized controlled trials involving integrative medicine or complementary and alternative medicine treatment for cancer patients. Review Methods Trials were drawn from a systematic PubMed database search categorized into cancer prevention, treatment, and symptom management. Conclusions Integrative medicine is gaining popularity for the management of cancer and is most commonly used for symptom management. A number of randomized controlled trials provide data to support integrative therapies, yet physicians who treat head and neck cancer may be faced with ethical dilemmas and practical barriers surrounding incorporation of integrative medicine. Implications for Practice In the management of head and neck cancer, there is an increasing demand for awareness of, dialogue about, and research evaluating integrative medicine therapies. It is important for otolaryngologists to become aware of integrative therapy options, their risks and benefits, and resources for further information to effectively counsel their patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058131984

Download citation: RISBibTeXText

PMID: 27729559

DOI: 10.1177/0194599816671885


Related references

Performance and standards for the process of head and neck cancer care: South and West audit of head and neck cancer 1996-1997 (SWAHN I). South and West Regional Cancer Organisation Tumour Panel for Head and Neck Cancer. British Journal of Cancer 83(4): 421-425, 2000

Dietary habits and Helicobacter pylori infection: a cross sectional study at a Lebanese hospital. Bmc Gastroenterology 18(1): 48, 2018

Integrative molecular characterization of head and neck cancer cell model genomes. Head and Neck 32(9): 1143-1160, 2010

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Clinical Cancer Research 21(4): 870-881, 2015

Antibodies combined with radiotherapy in the curative treatment of head and neck cancer. Danish Society of Head-Neck Oncology and Danish Head-Neck Cancer Group. Ugeskrift for Laeger 167(12-13): 1391, 2005

Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22). Journal of Pain and Symptom Management 46(1): 113-120, 2013

Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer 123(7): 1259-1271, 2017

EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. Journal of the National Cancer Institute 92(12): 977-986, 2000

Sentinel node in head and neck cancer: use of size criterion to upstage the no neck in head and neck squamous cell carcinoma. Head and Neck 29(2): 95, 2007

Case of Sciatica Depending on Pressure by an Intrapelvic Tumour. Edinburgh Medical Journal 20(5): 402-404, 1874

Nuclear medicine in diagnosis and treatment of diseases of the head and neck 1. salivary and parathyroid gland disease and 1 identification and staging of head and neck tumors. Head & Neck Surgery 4(2): 129-135, 1981

Nuclear medicine in diagnosis and treatment of diseases of the head and neck. I. Salivary and parathyroid gland disease and one identification and staging of head and neck tumors. Head and Neck Surgery 4(2): 129-135, 1981

Performance and standards for the process of head and neck cancer care: South and West audit of head and neck cancer 1996-1997 (SWAHN I). European Journal of Cancer 36(Suppl. 2): 421-425, 2000

Nutrient-based dietary patterns and the risk of head and neck cancer: a pooled analysis in the International Head and Neck Cancer Epidemiology consortium. Annals of Oncology 23(7): 1869-1880, 2012

Recreational physical activity and risk of head and neck cancer: a pooled analysis within the international head and neck cancer epidemiology (INHANCE) Consortium. European Journal of Epidemiology 26(8): 619-628, 2011